Real-world evidence for improved outcomes with histamine antagonists and aspirin in 22,560 COVID-19 patients

Signal Transduct Target Ther. 2021 Jul 14;6(1):267. doi: 10.1038/s41392-021-00689-y.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Comment

MeSH terms

  • Aspirin* / therapeutic use
  • COVID-19*
  • Histamine Antagonists
  • Histamine H2 Antagonists
  • Humans
  • SARS-CoV-2

Substances

  • Histamine Antagonists
  • Histamine H2 Antagonists
  • Aspirin